Quidel | QDEL - Gross Profit On Sales

Stock Price
29.10
Daily Change
0.41 1.43%
Monthly
-12.80%
Yearly
-32.15%
Q1 Forecast
26.33

Quidel reported $-733M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Agilent USD 990M 102M Sep/2025
Avanos Medical USD 86M 6.1M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Bruker USD 379.4M 21.5M Sep/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Illumina USD 759M 26M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Neogen USD 94.97M 2.11M Jun/2025
Quidel USD -733M 1.01B Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
STAAR Surgical USD 77.88M 45.08M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 459.99M 21.97M Sep/2025